Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis

Veterinary Dermatology

Volumn 18, Issue 2, 2007, Pages 78-86

  Olivry, Thierry ^a,e   Marsella, Rosanna ^b,e   Iwasaki, Toshiroh ^c,e   Mueller, Ralf ^d,e   Bensignor, Emmanuel ^e   Carlotti, Didier ^e   DeBoer, Douglas J ^e   Griffin, Craig ^e   Halliwell, Richard ^e   Hammerberg, Bruce ^e   Hill, Peter ^e   Jackson, Hilary ^e   Maeda, Sadatoshi ^e   Masuda, Kenichi ^e   Nuttall, Tim ^e   Prélaud, Pascal ^e   Sousa, Candace ^e   Willemse, Ton ^e  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^d UNIVERSITY OF MUNICH   (Germany)

^e College of Veterinary Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

EID: 33847769283     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2007.00569.x     Document Type: Article

References (32)

1. Olivry T, DeBoer DJ, Griffin CE et al. The ACVD task force on canine atopic dermatitis: forewords and lexicon. Veterinary Immunology and Immunopathology 2001; 81: 143-6.
2. Yoxall AT. A clinical trial of oxatomide in canine atopic dermatitis. Trends in Veterinary Pharmacology and Toxicology 1980; 6: 348-9.
3. Olivry T, Mueller RS. Evidence-based veterinary dermatology: a systematic review of the pharmacotherapy of canine atopic dermatitis. Veterinary Dermatology 2003; 14: 121-46.
4. Scott DW, Buerger RG. Nonsteroidal antiinflammatory agents in the management of canine pruritus. Journal of the American Animal Hospital Association 1988; 24: 425-8.
5. Miller WH, Griffin CE, Scott DW et al. Clinical trial of DVM Derm Caps in the treatment of allergic disease in dogs: a nonblinded study. Journal of the American Animal Hospital Association 1989; 25: 163-8.
6. Scott DW, Miller WH. Nonsteroidal management of canine pruritus: chlorpheniramine and a fatty acid (Suppl.) (DVM Derm Caps) in combination, and the fatty acid supplement at twice the manufacturer's recommended dosage. Cornell Veterinarian 1990; 80: 381-7.
7. Paradis M, Scott DW, Giroux D. Further investigations on the use of nonsteroidal and steroidal antiinflammatory agents in the management of canine pruritus. Journal of the American Animal Hospital Association 1991; 27: 44-8.
8. Miller WH, Scott DW, Wellington JR. Investigation on the anti-pruritic effects of ascorbic acid given alone and in combination with a fatty acid supplement to dogs with allergic skin disease. Canine Practice 1992; 17: 11-3.
9. Miller WH, Scott DW, Wellington JR. Nonsteroidal management of canine pruritus with amitriptyline. Cornell Veterinarian 1992; 82: 53-7.
10. Willemse A, van den Brom WE, Rijnberg A. Effect of hyposensitization on atopic dermatitis in dogs. Journal of the American Veterinary Medical Association 1984; 184: 1277-80.
11. DeBoer DJ, Moriello KA, Pollet RA. The efficacy of AHR-13268, an anti-allergenic compound, in the management of pruritus caused by atopic disease in dogs. American Journal of Veterinary Research 1992; 53: 532-6.
12. Bond R, Lloyd DH. Double-blind comparison of three concentrated essential fatty acid supplements in the management of canine atopy. Veterinary Dermatology 1993; 4: 185-9.
13. Bond R, Lloyd DH. Combined treatment with concentrated essential fatty acids and prednisolone in the management of canine atopy. Veterinary Record 1994; 134: 30-2.
14. Deboer DJ, Moriello KA, Pollet RA. Inability of a short duration treatment with a lipoxygenase inhibitor to reduce clinical signs of canine atopy. Veterinary Dermatology 1994; 5: 13-6.
15. Lloyd DH, Thomsett LR. Essential fatty acid supplementation in the treatment of canine atopy: a preliminary study. Veterinary Dermatology 1989; 1: 41-4.
16. Scarff DH, Lloyd DH. Double blind, placebo-controlled, crossover study of evening primrose oil in the treatment of canine atopy. Veterinary Record 1992; 13: 97-9.
17. Olivry T, Guaguère E, Héripret D. Treatment of canine atopic dermatitis with the prostaglandin E1 analog misoprostol: an open study. Journal of Dermatological Treatment 1997; 8: 243-7.
18. Olivry T, Rivierre C, Jackson HA et al. Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial. Veterinary Dermatology 2002; 13: 77-87.
19. Olivry T, Steffan J, Fisch RD et al. Randomized controlled trial of the efficacy of cyclosporine in the treatment of atopic dermatitis in dogs. Journal of the American Veterinary Medical Association 2002; 221: 370-7.
20. Crow DW, Marsella R, Nicklin CF. Double-blinded, placebo-controlled, cross-over pilot study on the efficacy of zileuton for canine atopic dermatitis. Veterinary Dermatology 2001; 12: 189-95.
21. Ewert G, Daems T. Traitement de la dermite atopique canine par un copolymere d'acides gras: une etude clinique comparative en double aveugle (Treatment of canine atopic dermatitis by a fatty acid copolymer: comparative double blind study). Pratique Medicale et Chirurgicale de L Animal de Compagnie 2001; 36: 401-8.
22. Nagle TM, Torres SM, Horne KL et al. A randomized, double-blind, placebo-controlled trial to investigate the efficacy and safety of a Chinese herbal product (P07P) for the treatment of canine atopic dermatitis. Veterinary Dermatology 2001; 12: 265-74.
23. Carlotti DN, Madiot G, Ducret J et al. Use of recombinant omega interferon therapy in canine atopic dermatitis (Abstract). Veterinary Dermatology 2004; 15 (Suppl. 1): 32.
24. Colombo S, Hill PB, Shaw DJ et al. Effectiveness of low dose immunotherapy in the treatment of canine atopic dermatitis: a prospective, double-blinded, clinical study. Veterinary Dermatology 2005; 16: 162-70.
25. Charman C, Williams H. Outcome measures of disease severity in atopic eczema. Archives of Dermatology 2000; 136: 763-9.
26. Germain PA, Prelaud P, Bensignor E. CADESI (Canine Atopic Dermatitis Extent and Severity Index) reproducibility. Revue de Medecine Veterinaire 2005; 156: 382-5.
27. DeBoer DJ, Hillier A. The ACVD task force on canine atopic dermatitis (XV): fundamental concepts in clinical diagnosis. Veterinary Immunology and Immunopathology 2001; 81: 271-6.
28. Favrot C, Reichmuth P, Olivry T. Treatment of canine atopic dermatitis with azathioprine: a pilot study. Veterinary Record 2006; in press.
29. Charman C, Chambers C, Williams H. Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring? Journal of Investigative Dermatology 2003; 120: 932-41.
30. Thestrup-Pedersen K. Clinical aspects of atopic dermatitis. Clinical and Experimental Dermatology 2000; 25: 535-43.
31. Charman C, Venn AJ, Williams HC. Patient-based outcome measures for atopic dermatitis (Abstract). British Journal of Dermatology 2000; 143 (Suppl. 57): 34.
32. Steffan J, Alexander D, Brovedani F et al. Comparison of cyclosporine A with methylprednisolone for treatment of canine atopic dermatitis: a parallel blinded randomized controlled trial. Veterinary Dermatology 2003; 14: 11-22.